Loading...

Sally M Blower

Title(s)Professor-in-Residence, Psychiatry and Biobehavioral Sciences
SchoolMedicine
Address760 Westwood Plaza B8-146
Los Angeles CA 90024
Phone43933
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Optimal Strategies for HIV Treatment and Prevention in Sub-Saharan Africa
    NIH/NIAID R01AI116493Aug 1, 2015 - Jan 31, 2020
    Role: Principal Investigator
    Determining whether TasP could eliminate HIV in resource-rich countries
    NIH/NIAID R21AI114478Jun 15, 2014 - May 31, 2016
    Role: Principal Investigator
    Designing optimal interventions to control HIV in Africa using data-based models
    NIH/NIAID R21AI086701Jul 1, 2010 - Jun 30, 2012
    Role: Principal Investigator
    HIV - Emergence of Drug Resistance
    NIH/NIAID R56AI041935May 1, 1998 - Jul 31, 2015
    Role: Principal Investigator
    HIV - Emergence of Drug Resistance
    NIH/NIAID R01AI041935May 1, 1998 - Sep 19, 2011
    Role: Principal Investigator
    DIFFUSION OF HIV EPIDEMICS
    NIH/NIDA R29DA008153Mar 1, 1993 - Feb 28, 1998
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Preventing major outbreaks of COVID-19 in jails. Lancet. 2020 05 16; 395(10236):1542-1543. Okano JT, Blower S. PMID: 32423582.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    2. HIV transmission and source-sink dynamics in sub-Saharan Africa. Lancet HIV. 2020 03; 7(3):e209-e214. Okano JT, Sharp K, Valdano E, Palk L, Blower S. PMID: 32066532.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    3. Universal Testing and Treatment for HIV Infection in Botswana. N Engl J Med. 2019 11 28; 381(22):2180. Valdano E, Blower S. PMID: 31774970.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Precision public health and HIV in Africa. Lancet Infect Dis. 2019 10; 19(10):1050-1052. Blower S, Okano JT. PMID: 31559952.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    5. New conceptual framework for tuberculosis transmission. Lancet Infect Dis. 2019 06; 19(6):578. Okano JT, Blower S. PMID: 31122773.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. A modeling study of the Danish HIV epidemic in men who have sex with men: travel, pre-exposure prophylaxis and elimination. Sci Rep. 2018 10 30; 8(1):16003. Palk L, Gerstoft J, Obel N, Blower S. PMID: 30375426.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    7. Geographic variation in sexual behavior can explain geospatial heterogeneity in the severity of the HIV epidemic in Malawi. BMC Med. 2018 02 09; 16(1):22. Palk L, Blower S. PMID: 29422096.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    8. Response to comment on "Using geospatial mapping to design HIV elimination strategies for sub-Saharan Africa". Sci Transl Med. 2017 Aug 02; 9(401). Okano JT, Coburn BJ, Blower S. PMID: 28768805.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    9. Methodological concerns regarding a PrEP model. Lancet Infect Dis. 2017 05; 17(5):482. Blower S, Palk L. PMID: 28447954.
      View in: PubMed   Mentions:    Fields:    Translation:PHPublic Health
    10. Using geospatial mapping to design HIV elimination strategies for sub-Saharan Africa. Sci Transl Med. 2017 03 29; 9(383). Coburn BJ, Okano JT, Blower S. PMID: 28356504.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    11. Sex-specific maps of HIV epidemics in sub-Saharan Africa. Lancet Infect Dis. 2016 12; 16(12):1320-1322. Okano JT, Blower S. PMID: 27998582.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    12. HIV elimination and population viral load. Lancet HIV. 2016 11; 3(11):e507-e509. Okano JT, Gerstoft J, Obel N, Blower S. PMID: 27788865.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    13. Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men. Lancet Infect Dis. 2016 07; 16(7):789-796. Okano JT, Robbins D, Palk L, Gerstoft J, Obel N, Blower S. PMID: 27174504.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    14. Mapping divided households and residency changes: the effect of couple separation on sexual behavior and risk of HIV infection. Sci Rep. 2015 Dec 02; 5:17598. Palk L, Blower S. PMID: 26626310.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Corrigendum: Modeling dynamic interactions between pre-exposure prophylaxis interventions &treatment programs: predicting HIV transmission &resistance. Sci Rep. 2015 Sep 18; 5:13037. Supervie V, Barrett M, Kahn JS, Musuka G, Moeti TL, Busang L, Blower S. PMID: 26384032.
      View in: PubMed   Mentions:    Fields:    
    16. Brief report: Mobility and circular migration in Lesotho: implications for transmission, treatment, and control of a severe HIV epidemic. . 2015 Apr 15; 68(5):604-8. Palk L, Blower S. PMID: 25763787.
      View in: PubMed   Mentions:
    17. Combination HIV prevention and the battle of the sexes. Lancet Infect Dis. 2015 Mar; 15(3):261-3. Blower S, Palk L. PMID: 25749218.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    18. Using geospatial modelling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa. Nat Commun. 2014 Dec 02; 5:5454. Gerberry DJ, Wagner BG, Garcia-Lerma JG, Heneine W, Blower S. PMID: 25462707.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    19. Maximising the effect of combination HIV prevention in Kenya. Lancet. 2014 Oct 18; 384(9952):1426. Blower S, Coburn BJ. PMID: 25390322.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Beware of using invalid transmission models to guide HIV health policy. Lancet Glob Health. 2014 May; 2(5):e260. Okano JT, Blower S. PMID: 25103162.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Predicting the potential for within-flight transmission and global dissemination of MERS. Lancet Infect Dis. 2014 Feb; 14(2):99. Coburn BJ, Blower S. PMID: 24457166.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    22. Mapping HIV epidemics in sub-Saharan Africa with use of GPS data. Lancet Glob Health. 2013 Nov; 1(5):e251-3. Coburn BJ, Blower S. PMID: 25104487.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    23. Current drivers and geographic patterns of HIV in Lesotho: implications for treatment and prevention in Sub-Saharan Africa. BMC Med. 2013 Oct 16; 11:224. Coburn BJ, Okano JT, Blower S. PMID: 24131484.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    24. HIV treatment, preexposure prophylaxis, and drug resistance: reconciling conflicting predictions from mathematical models. J Infect Dis. 2014 Jan 01; 209(1):163-4. Okano JT, Blower S. PMID: 24133183.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    25. Increasing survival time decreases the cost-effectiveness of using "test & treat'' to eliminate HIV epidemics. Math Biosci Eng. 2013 Oct-Dec; 10(5-6):1673-86. Wagner BG, Coburn BJ, Blower S. PMID: 24245641.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    26. A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control. AIDS. 2012 Sep 24; 26(15):1969-71. Coburn BJ, Blower S. PMID: 22824631.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    27. Universal access to HIV treatment versus universal 'test and treat': transmission, drug resistance & treatment costs. PLoS One. 2012; 7(9):e41212. Wagner BG, Blower S. PMID: 22957012.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsPHPublic Health
    28. Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks. Sci Rep. 2012; 2:320. Wagner BG, Garcia-Lerma JG, Blower S. PMID: 22432052.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    29. Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance. Sci Rep. 2011; 1:185. Supervie V, Barrett M, Kahn JS, Musuka G, Moeti TL, Busang L, Busang L, Blower S. PMID: 22355700.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    30. Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission. AIDS. 2011 Nov 28; 25(18):2295-9. El-Sadr WM, Coburn BJ, Blower S. PMID: 21993304.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    31. Human papillomavirus vaccination programs and human immunodeficiency virus epidemics. Clin Infect Dis. 2011 Oct; 53(8):845-6. Yasmin S, Gerberry DJ, Blower S. PMID: 21921228.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    32. Quantification of the role of discordant couples in driving incidence of HIV in sub-Saharan Africa. Lancet Infect Dis. 2011 Apr; 11(4):263-4. Coburn BJ, Gerberry DJ, Blower S. PMID: 21453868.
      View in: PubMed   Mentions: 19     Fields:    Translation:Cells
    33. Assessing the impact of mass rape on the incidence of HIV in conflict-affected countries. AIDS. 2010 Nov 27; 24(18):2841-7. Supervie V, Halima Y, Blower S. PMID: 20859191.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    34. Costs of eliminating HIV in South Africa have been underestimated. Lancet. 2010 Sep 18; 376(9745):953-4. Wagner B, Blower S. PMID: 20851250.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    35. HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis. Proc Natl Acad Sci U S A. 2010 Jul 06; 107(27):12381-6. Supervie V, García-Lerma JG, Heneine W, Blower S. PMID: 20616092.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    36. Predicting the level of vaccine-induced cross-immunity necessary to eliminate HIV epidemics composed of multiple subtypes. AIDS. 2010 Jun 19; 24(10):1604-406. Gerberry DJ, Blower S. PMID: 20539095.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    37. A major HIV risk factor for young men who have sex with men is sex with older partners. . 2010 Jun; 54(2):113-4. Coburn BJ, Blower S. PMID: 20335817.
      View in: PubMed   Mentions:
    38. Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco. Science. 2010 Feb 05; 327(5966):697-701. Smith RJ, Okano JT, Kahn JS, Bodine EN, Blower S. PMID: 20075214.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCellsPHPublic Health
    39. Are correctional facilities amplifying the epidemic of community-acquired methicillin-resistant Staphylococcus aureus? Nat Rev Microbiol. 2010 Jan; 8(1):83. Okano JT, Blower S. PMID: 20010953.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    40. Calculating the potential for within-flight transmission of influenza A (H1N1). BMC Med. 2009 Dec 24; 7:81. Wagner BG, Coburn BJ, Blower S. PMID: 20034378.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    41. Quantifying the treatment efficacy of reverse transcriptase inhibitors: new analyses of clinical data based on within-host modeling. BMC Public Health. 2009 Nov 18; 9 Suppl 1:S11. Breban R, Napravnik S, Kahn J, Blower S. PMID: 19922681.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Med. 2009 Jun 22; 7:30. Coburn BJ, Wagner BG, Blower S. PMID: 19545404.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCellsPHPublic Health
    43. Is there any evidence that syphilis epidemics cycle? Lancet Infect Dis. 2008 Sep; 8(9):577-81. Breban R, Supervie V, Okano JT, Vardavas R, Blower S. PMID: 18718441.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    44. The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proc Natl Acad Sci U S A. 2008 Jul 15; 105(28):9835-40. Wilson DP, Coplan PM, Wainberg MA, Blower SM. PMID: 18606986.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    45. Infectious syphilis in high-income settings in the 21st century. Lancet Infect Dis. 2008 Apr; 8(4):244-53. Fenton KA, Breban R, Vardavas R, Okano JT, Martin T, Aral S, Blower S. PMID: 18353265.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    46. Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines. Hum Vaccin. 2007 Nov-Dec; 3(6):231-8. Schwartz EJ, Bodine EN, Blower S. PMID: 17881889.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    47. Mean-field analysis of an inductive reasoning game: application to influenza vaccination. Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Sep; 76(3 Pt 1):031127. Breban R, Vardavas R, Blower S. PMID: 17930219.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    48. Modelling an outbreak of an emerging pathogen. Nat Rev Microbiol. 2007 09; 5(9):700-9. Kajita E, Okano JT, Bodine EN, Layne SP, Blower S. PMID: 17703226.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCellsPHPublic Health
    49. Predicting the future of XDR tuberculosis. Lancet Infect Dis. 2007 Jul; 7(7):443. Blower S, Supervie V. PMID: 17597567.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    50. How far will we need to go to reach HIV-infected people in rural South Africa? BMC Med. 2007 Jun 19; 5:16. Wilson DP, Blower S. PMID: 17577418.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    51. Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling. Sex Transm Infect. 2007 Aug; 83(5):359-64. Crespi CM, Cumberland WG, Wald A, Corey L, Blower S. PMID: 17475687.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    52. Can influenza epidemics be prevented by voluntary vaccination? PLoS Comput Biol. 2007 May; 3(5):e85. Vardavas R, Breban R, Blower S. PMID: 17480117.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    53. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med. 2007 Apr 17; 146(8):591-601. Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L. PMID: 17438318.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansAnimalsCells
    54. Theory versus data: how to calculate R0? PLoS One. 2007 Mar 14; 2(3):e282. Breban R, Vardavas R, Blower S. PMID: 17356693.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    55. The emergence of HIV transmitted resistance in Botswana: "when will the WHO detection threshold be exceeded?". PLoS One. 2007 Jan 17; 2(1):e152. Vardavas R, Blower S. PMID: 17225857.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    56. Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: the effect of the urban-rural divide. Proc Natl Acad Sci U S A. 2006 Sep 19; 103(38):14228-33. Wilson DP, Kahn J, Blower SM. PMID: 16968786.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    57. Modeling the potential impact of rectal microbicides to reduce hiv transmission in bathhouses. Math Biosci Eng. 2006 Jul; 3(3):459-66. Breban R, McGowan I, Topaz C, Schwartz EJ, Anton P, Blower S. PMID: 20210374.
      View in: PubMed   Mentions: 9     Fields:    
    58. Role of parametric resonance in virological failure during HIV treatment interruption therapy. Lancet. 2006 Apr 15; 367(9518):1285-9. Breban R, Blower S. PMID: 16631884.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    59. Rational choices for allocating antiretrovirals in Africa: treatment equity, epidemiological efficiency, and feasibility. PLoS Med. 2006 Mar; 3(3):e160. Wilson DP, Blower SM. PMID: 16563042.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    60. Response to Foss et al., 'Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently'. AIDS. 2005 Nov 18; 19(17):2044-6. Wilson DP, Bodine EN, Smith RJ, Blower SM. PMID: 16260916.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Modeling the potential public health impact of imperfect HIV vaccines. J Infect Dis. 2005 Oct 15; 192(8):1494-5; author reply 1495-6. Blower S. PMID: 16170769.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    62. Linking population-level models with growing networks: a class of epidemic models. Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Oct; 72(4 Pt 2):046110. Breban R, Vardavas R, Blower S. PMID: 16383471.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsPHPublic Health
    63. Allocating antiretrovirals in South Africa: using modeling to determine treatment equity. PLoS Med. 2005 Jun; 2(6):e155; author reply e186. Wilson DP, Blower SM. PMID: 15971938.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. Predicting the potential public health impact of disease-modifying HIV vaccines in South Africa: the problem of subtypes. Curr Drug Targets Infect Disord. 2005 Jun; 5(2):179-92. Blower SM, Bodine EN, Grovit-Ferbas K. PMID: 15975023.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    65. Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines. J Infect Dis. 2005 May 15; 191(10):1734-46. Schwartz EJ, Blower S. PMID: 15838802.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    66. Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers. AIDS. 2005 Mar 04; 19(4):413-21. Smith RJ, Bodine EN, Wilson DP, Blower SM. PMID: 15750395.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    67. A queueing model for chronic recurrent conditions under panel observation. Biometrics. 2005 Mar; 61(1):193-8. Crespi CM, Cumberland WG, Blower S. PMID: 15737093.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    68. Designing equitable antiretroviral allocation strategies in resource-constrained countries. PLoS Med. 2005 Feb; 2(2):e50. Wilson DP, Blower SM. PMID: 15737005.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    69. The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS. 2005 Jan 03; 19(1):1-14. Blower S, Bodine E, Kahn J, McFarland W. PMID: 15627028.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCellsPHPublic Health
    70. Microbicides: anti-HIV efficacy and ethics. Science. 2004 Dec 10; 306(5703):1890; author reply 1890. Wilson DP, Blower SM. PMID: 15591184.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    71. Calculating the contribution of herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications. Clin Infect Dis. 2004 Nov 01; 39 Suppl 5:S240-7. Blower S, Ma L. PMID: 15494895.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    72. Could disease-modifying HIV vaccines cause population-level perversity? Lancet Infect Dis. 2004 Oct; 4(10):636-9. Smith RJ, Blower SM. PMID: 15451492.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    73. Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics. J Infect Dis. 2004 Nov 01; 190(9):1610-7. Blower S, Wald A, Gershengorn H, Wang F, Corey L. PMID: 15478066.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    74. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nat Med. 2004 Oct; 10(10):1111-6. Blower SM, Chou T. PMID: 15378053.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCellsPHPublic Health
    75. Potential public health impact of new tuberculosis vaccines. Emerg Infect Dis. 2004 Sep; 10(9):1529-35. Ziv E, Daley CL, Blower S. PMID: 15498152.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    76. Modelling the genital herpes epidemic. Herpes. 2004 Aug; 11 Suppl 3:138A-146A. Blower S. PMID: 15319083.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance. Curr Drug Targets Infect Disord. 2003 Dec; 3(4):345-53. Blower S, Ma L, Farmer P, Koenig S. PMID: 14754434.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    78. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. AIDS Rev. 2003 Apr-Jun; 5(2):113-25. Blower S, Schwartz EJ, Mills J. PMID: 12876900.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    79. Predicting the emergence of drug-resistant HSV-2: new predictions. BMC Infect Dis. 2003 Mar 24; 3:1. Gershengorn HB, Darby G, Blower SM. PMID: 12659657.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    80. Predicting the transmission of drug-resistant HIV: comparing theory with data. Lancet Infect Dis. 2003 Jan; 3(1):10-1. Blower SM, Aschenbach AN, Kahn JO. PMID: 12505024.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    81. What can modeling tell us about the threat of antiviral drug resistance? Curr Opin Infect Dis. 2002 Dec; 15(6):609-14. Blower S, Volberding P. PMID: 12821838.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    Sally's Networks
    Concepts (201)
    Derived automatically from this person's publications.
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _